CY1123430T1 - Μη-ευπεπτες καψουλες για τη διανομη υγρο-απορροφητικων υλικων - Google Patents

Μη-ευπεπτες καψουλες για τη διανομη υγρο-απορροφητικων υλικων

Info

Publication number
CY1123430T1
CY1123430T1 CY20201100320T CY201100320T CY1123430T1 CY 1123430 T1 CY1123430 T1 CY 1123430T1 CY 20201100320 T CY20201100320 T CY 20201100320T CY 201100320 T CY201100320 T CY 201100320T CY 1123430 T1 CY1123430 T1 CY 1123430T1
Authority
CY
Cyprus
Prior art keywords
liquid
distribution
absorbent materials
capsules
product
Prior art date
Application number
CY20201100320T
Other languages
English (en)
Inventor
Danielle Berger
Original Assignee
Hb Biotechnologies Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hb Biotechnologies Corporation filed Critical Hb Biotechnologies Corporation
Publication of CY1123430T1 publication Critical patent/CY1123430T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Η εφεύρεση αναφέρεται σε ένα προϊόν, μέθοδο χρήσης και/ή μέθοδο παρασκευής μιας κάψουλας ή καψουλοειδούς προϊόντος που περιλαμβάνει υδρόφιλα υγρο-απορροφητικά υλικά που δεσμεύουν, παγιδεύουν και/ή απορροφούν μεγάλες ποσότητες υγρού. Οι κάψουλες ή το καψουλοειδές προϊόν μπορεί να έχουν την ικανότητα να εκτρέπουν τον τρόπο απόρριψης των υγρών και αποβλήτων από τη νεφρική προς τη γαστρεντερική οδό.
CY20201100320T 2011-08-01 2020-04-02 Μη-ευπεπτες καψουλες για τη διανομη υγρο-απορροφητικων υλικων CY1123430T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161513923P 2011-08-01 2011-08-01
US201161523787P 2011-08-15 2011-08-15
PCT/US2012/049209 WO2013019891A1 (en) 2011-08-01 2012-08-01 Non-digestible capsules for the delivery of fluid absorbing materials

Publications (1)

Publication Number Publication Date
CY1123430T1 true CY1123430T1 (el) 2021-12-31

Family

ID=47629668

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100320T CY1123430T1 (el) 2011-08-01 2020-04-02 Μη-ευπεπτες καψουλες για τη διανομη υγρο-απορροφητικων υλικων

Country Status (15)

Country Link
US (2) US20150216808A1 (el)
EP (1) EP2739270B1 (el)
JP (2) JP2014521689A (el)
CA (1) CA2842802C (el)
CY (1) CY1123430T1 (el)
DK (1) DK2739270T3 (el)
ES (1) ES2782523T3 (el)
HR (1) HRP20200463T1 (el)
HU (1) HUE049186T2 (el)
LT (1) LT2739270T (el)
PL (1) PL2739270T3 (el)
PT (1) PT2739270T (el)
RS (1) RS60294B1 (el)
SI (1) SI2739270T1 (el)
WO (1) WO2013019891A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11484579B2 (en) * 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE169293C1 (el) 1958-03-13 1959-11-10
US3042667A (en) 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
SE319903B (el) 1964-01-31 1970-01-26 Pharmacia Ab
US3300474A (en) 1964-02-12 1967-01-24 Pharmacia Ab Sucrose ether copolymerizates
US3518340A (en) 1968-04-15 1970-06-30 Dow Corning Method of forming silicone rubber drug carriers
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US4470975A (en) * 1977-10-21 1984-09-11 The Johns Hopkins University Method and composition for the elimination of water from an animal body
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4663148A (en) * 1984-03-21 1987-05-05 Alza Corporation Dispenser comprising telescopically engaging members
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
EP0458887A1 (en) * 1989-02-16 1991-12-04 Btg International Limited Dispensing device
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
JP3238350B2 (ja) 1997-05-27 2001-12-10 三粧化研株式会社 可食性パール状カプセルおよびその製造法
US6908609B2 (en) * 2000-11-20 2005-06-21 Dow Global Technologies Inc. In vivo use of water absorbent polymers
US20040105895A1 (en) * 2001-02-06 2004-06-03 Ash Stephen R Monovalent-selective cation exchangers as oral sorbent therapy
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
AU2003275329B2 (en) * 2002-09-13 2008-04-03 Cydex Pharmaceuticals, Inc. Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
ES2274163T3 (es) * 2003-12-04 2007-05-16 Cognis Ip Management Gmbh Preparacion para su aplicacion (i) oral y/o topica.
JPWO2005084649A1 (ja) 2004-03-04 2007-11-29 武田薬品工業株式会社 安定なカプセル剤
EP1931319A2 (en) * 2005-08-09 2008-06-18 Tylerton International Inc. Satiety
EP1991196B1 (en) 2006-03-03 2016-10-12 Fmc Corporation Method and apparatus for the preparation of capsules.
EP2004106B1 (en) * 2006-03-29 2012-05-30 Eatlittle Inc. Ingestible implement for weight control
US20080268045A1 (en) * 2006-11-09 2008-10-30 Proprius Pharmaceuticals, Inc. Sustained release methotrexate formulations and methods of use thereof
GB0625180D0 (en) * 2006-12-15 2007-01-24 Mw Encap Ltd Improved hard shell capsules
CN101835500B (zh) * 2007-08-29 2014-05-28 吸附剂治疗学公司 具有可变抗衡离子含量的吸收性聚合物组合物及其制备方法和用途
WO2009049105A2 (en) * 2007-10-09 2009-04-16 Gelesis, Inc. Methods for inducing satiation
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
US8101203B2 (en) * 2010-01-14 2012-01-24 Karl Wei Cao Hard capsule composition and method of use

Also Published As

Publication number Publication date
JP2014521689A (ja) 2014-08-28
DK2739270T3 (da) 2020-04-06
PL2739270T3 (pl) 2020-10-05
WO2013019891A1 (en) 2013-02-07
RS60294B1 (sr) 2020-07-31
JP2017081973A (ja) 2017-05-18
LT2739270T (lt) 2020-07-10
HRP20200463T1 (hr) 2020-06-26
EP2739270A4 (en) 2015-01-14
JP6446071B2 (ja) 2018-12-26
US20150216808A1 (en) 2015-08-06
PT2739270T (pt) 2020-04-02
US20210330595A1 (en) 2021-10-28
CA2842802C (en) 2020-03-10
EP2739270A1 (en) 2014-06-11
ES2782523T3 (es) 2020-09-15
EP2739270B1 (en) 2020-01-01
HUE049186T2 (hu) 2020-09-28
SI2739270T1 (sl) 2020-10-30
CA2842802A1 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
CY1119746T1 (el) Φαρμακευτικες μορφοποιησεις που περιεχουν ριφαξιμινη, διαδικασιες για τη ληψη τους και μεθοδος αγωγης εντερικων νοσων
DK3331910T3 (da) Monoklonale antistoffer mod humant b-cellemodningsantigen (bcma)
CY1115639T1 (el) Διειδικα αγωνιστικα αντισωματα υποδοχεα θανατου
JP2018536676A5 (ja) 抗ｐｄ−ｌ１抗体アベルマブを含む水性医薬製剤
CU20170169A7 (es) Anticuerpos de factor xi
SG11202009510UA (en) Modified polyamines grafted to a particulate, solid support as sorbent materials for removal of target substances from fluids
CL2013003043A1 (es) Anticuerpos de un único dominio variable dab que se unen a cd40 humano; ácido nucleico que codifica dicho anticuerpo; vector y célula huésped que lo comprenden; composición farmacéutica; uso de dichos anticuerpos para tratar enfermedad inmune.
JP2014520248A5 (el)
CL2013001187A1 (es) Metodo para la preparacion de un filtro catalizado de material particulado; y filtro catalizado de material particulado.
JP2012031178A5 (el)
DK2928923T3 (da) Antistoffer mod dendritisk celle-antigen 2 fra blod og anvendelser deraf
BR112013013183A2 (pt) sistema para liberar material particulado sólido para carregamento
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
CL2014000204A1 (es) Construcción de unión de antígeno que comprende dos anticuerpos de dominio (dabs) separados por una región fc; metodo para construir dicha construcción.
FI20100180A (fi) Lääketieteellinen röntgenkuvauslaitteisto
DK3339865T3 (da) Assay for jc-virus-antistoffer
CL2013001188A1 (es) Metodo para la preparacion de un filtro catalizado de material particulado; y filtro catalizado de material particulado.
PT2535358T (pt) Anticorpo anti-caderina marcado com metal radioativo
CO6920281A2 (es) Sistema de revestimiento de contención para derrames ampliamente, modular
FR2973684B1 (fr) Cage intervertebrale pour la fusion.
DK2723760T3 (da) Fremgangsmåde til separering af biopolymeraggregater og virusser fra et fluid
EA201400447A1 (ru) АНТИТЕЛА К CD1d
BR112017009063A2 (pt) separadores de compostos para tubos de coleta de sangue
CY1123430T1 (el) Μη-ευπεπτες καψουλες για τη διανομη υγρο-απορροφητικων υλικων
FI20135143L (fi) Menetelmä vasta-aineen aktivoidun potensoidun muodon tehon lisäämiseksi